http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. (HealthDay)—Bayer HealthCare has received approval from the U.S. Food and Drug Administration for its new low-dose levonorgestrel-releasing intrauterine system (IUS) called Skyla, according a Jan. 10 news release issued by the company. http://medicalxpress.com/news/2013-01-bayer-fda-long-term-contraceptive.html Medications Fri, 11 Jan 2013 11:10:01 EST news277121357 (HealthDay)—Women with heavy menstrual bleeding may find some relief using an intrauterine device, or IUD, containing the hormone levonorgestrel, according to new research. http://medicalxpress.com/news/2013-01-iud-ease-heavy-menstrual.html Obstetrics & gynaecology Wed, 09 Jan 2013 18:20:01 EST news276976790 German drug maker Bayer said on Wednesday that European Union authorities had given the go-ahead for a new contraceptive which can prevent pregnancies for up to three years. http://medicalxpress.com/news/2012-12-eu-bayer-long-term-contraceptive-firm.html Medications Wed, 05 Dec 2012 05:40:03 EST news273906076 A new 90-day intravaginal ring has been developed—that for the first time—enables the long-lasting vaginal delivery of tenofovir (TFV), the only topical prophylactic shown to be effective at reducing the sexual transmission of human immunodeficiency virus (HIV) when formulated in a short-lasting gel. This research is being presented at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in Chicago, Ill., Oct. 14 – 18. http://medicalxpress.com/news/2012-10-intravaginal-hiv.html HIV & AIDS Tue, 16 Oct 2012 14:30:01 EST news269614823 (HealthDay) -- For women taking hormonal contraceptives, sex hormone-binding globulin (SHBG) is a useful marker to estimate the risk of venous thrombosis, according to research published in the June issue of the Journal of Thrombosis and Haemostasis. http://medicalxpress.com/news/2012-06-marker-thrombotic-hormonal-contraceptives.html Diseases, Conditions, Syndromes Fri, 08 Jun 2012 14:20:01 EST news258376813 (HealthDay) -- Women who undergo postpartum or interval insertion of Levonorgestrel-releasing Intrauterine System (LNG-IUS) or Copper T 380A (CU-T) intrauterine devices experience weight loss in the two years following insertion, according to a study presented at the annual clinical meeting of the American College of Obstetricians and Gynecologists, held from May 5 to 9 in San Diego. http://medicalxpress.com/news/2012-05-acog-intrauterine-device-insertion-linked.html Obstetrics & gynaecology Mon, 07 May 2012 17:00:11 EST news255626865 (HealthDay) -- U.S. health officials announced Tuesday that birth controls pills containing drospirenone -- a man-made version of the hormone progesterone -- may be associated with a higher risk of blood clots and will require new labels. http://medicalxpress.com/news/2012-04-birth-pills-higher-blood-clot.html Medications Tue, 10 Apr 2012 16:47:51 EST news253295261 (PhysOrg.com) -- Two new drug safety studies conducted by researchers at Boston University School of Medicine (BUSM) provide strong evidence that women taking oral contraception with drospirenone have an increased risk of nonfatal venous thromboembolism, or blood clots, compared to women taking oral contraception with levonorgestrel. http://medicalxpress.com/news/2011-04-blood-clots-oral-contraception-drospirenone.html Medications Thu, 21 Apr 2011 18:56:27 EST news222630963